AU1567588A - A pharmaceutical combination for the prophylaxis and therapy of malaria - Google Patents

A pharmaceutical combination for the prophylaxis and therapy of malaria

Info

Publication number
AU1567588A
AU1567588A AU15675/88A AU1567588A AU1567588A AU 1567588 A AU1567588 A AU 1567588A AU 15675/88 A AU15675/88 A AU 15675/88A AU 1567588 A AU1567588 A AU 1567588A AU 1567588 A AU1567588 A AU 1567588A
Authority
AU
Australia
Prior art keywords
malaria
prophylaxis
therapy
pharmaceutical combination
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU15675/88A
Other versions
AU614515B2 (en
Inventor
Dipak Kumar Chatterjee
Bansi Lal
Richard Helmut Rupp
Noel John De Souza
Bindumadhavan Venugopalan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU1567588A publication Critical patent/AU1567588A/en
Application granted granted Critical
Publication of AU614515B2 publication Critical patent/AU614515B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU15675/88A 1987-05-08 1988-05-06 A pharmaceutical combination for the prophylaxis and therapy of malaria Ceased AU614515B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3715378 1987-05-08
DE19873715378 DE3715378A1 (en) 1987-05-08 1987-05-08 COMBINATION OF MEDICINES ON PROPHYLAXIS AND THERAPY FROM MALARIA

Publications (2)

Publication Number Publication Date
AU1567588A true AU1567588A (en) 1988-11-10
AU614515B2 AU614515B2 (en) 1991-09-05

Family

ID=6327117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15675/88A Ceased AU614515B2 (en) 1987-05-08 1988-05-06 A pharmaceutical combination for the prophylaxis and therapy of malaria

Country Status (11)

Country Link
EP (1) EP0290959A3 (en)
JP (1) JPS6452714A (en)
KR (1) KR880013558A (en)
AU (1) AU614515B2 (en)
DE (1) DE3715378A1 (en)
DK (1) DK249688A (en)
HU (1) HU200688B (en)
IL (1) IL86302A0 (en)
IN (1) IN166154B (en)
PT (1) PT87427B (en)
ZA (1) ZA883209B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
DE68906345T2 (en) * 1988-10-07 1993-10-28 Hoechst Ag Antimalarial compositions utilizing quinidine, artemisinin and their derivatives.
EP0535719A3 (en) * 1988-12-06 1993-04-14 Dermatologic Research Corporation Treatment of hemorrhoids with artemisinin and derivates
EP0464233A1 (en) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pharmaceutical combinations against malaria
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof
GB9622427D0 (en) * 1996-10-28 1997-01-08 Pharma Mar Sa Antimalarial drugs
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
IN191696B (en) * 1999-02-12 2003-12-20 Council Scient Ind Res
CN1210030C (en) * 2000-03-28 2005-07-13 科学与工业研究委员会 Antimicrobial composition and mthod for producing same
US20040038933A1 (en) * 2000-10-20 2004-02-26 Yutaro Kaneko Pharmaceutical compositions, dose and method for treating malaria
CN1255106C (en) 2003-09-26 2006-05-10 李国桥 Complex artemisia apiacea extract
WO2006070393A1 (en) * 2004-12-28 2006-07-06 Council Of Scientific And Industrial Research SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA
FR2884715B1 (en) * 2005-04-20 2007-06-15 Sanofi Aventis Sa ASSOCIATION BETWEEN FERROQUIN AND AN ARTEMISININE DERIVATIVE FOR THE TREATMENT OF MALARIA
WO2007043061A1 (en) * 2005-10-11 2007-04-19 Ipca Laboratories Ltd. Anti-malarial combination and methods of formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
DE68906345T2 (en) * 1988-10-07 1993-10-28 Hoechst Ag Antimalarial compositions utilizing quinidine, artemisinin and their derivatives.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections

Also Published As

Publication number Publication date
IN166154B (en) 1990-03-24
DK249688D0 (en) 1988-05-06
JPS6452714A (en) 1989-02-28
HUT47846A (en) 1989-04-28
DK249688A (en) 1988-11-09
KR880013558A (en) 1988-12-21
EP0290959A2 (en) 1988-11-17
HU200688B (en) 1990-08-28
PT87427A (en) 1989-05-31
ZA883209B (en) 1988-11-08
PT87427B (en) 1992-09-30
EP0290959A3 (en) 1990-03-07
IL86302A0 (en) 1988-11-15
AU614515B2 (en) 1991-09-05
DE3715378A1 (en) 1988-11-24

Similar Documents

Publication Publication Date Title
AU1235088A (en) Pharmaceutical plaster
CS403391A3 (en) Pharmaceutical
AU8317587A (en) Therapeutic preparations
AU2914889A (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
AU1160088A (en) Cyclone
AU1567588A (en) A pharmaceutical combination for the prophylaxis and therapy of malaria
AU4477893A (en) Use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
AU570099B2 (en) Multilayer medicinal plaster
AU4365089A (en) Novel dosage form
AU2297388A (en) Therapeutic agents
AU2201888A (en) Pharmaceutical combination
AU6386390A (en) Therapeutic necleosides
AU3604289A (en) Treatment of arthritis
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
IL79900A0 (en) Combination preparations for the treatment of malaria
AU2143488A (en) Use of a compound for the treatment of sleep disorders and depression
AU3097689A (en) Medicaments
AU2187788A (en) Antimalaria vaccines
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
AU2065588A (en) Pharmaceutical preparations for external use
AU1509488A (en) Benzenesulfonamide derivatives and a process for the preparation thereof
AU4758190A (en) Pharmaceutical preparation
AU4158185A (en) A pharmaceutical product having an anti-tumor activity; the use of a pharmaceutical product or of pharmaceutical compositions in an anti-tumor therapy
AU2469088A (en) Pharmaceutical composition for the parenteral administration of navelbine
AU2203888A (en) The use of certain 6-mercaptopurines for the preparation of a pharmaceutical, and a process for the preparation of the pharmaceutical